STAT Plus: Biden’s health care AI czar, a new obesity company, and its dealmaking CEO
The Readout LOUD
STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come. Subscribe today on Apple, Google, Spotify, Soundcloud, Podcast Addict, and TuneIn.
Latest
Genentech’s cancer pivot, Pfizer’s sickle cell withdrawal, and a new schizophrenia drug
Cannabinoids for weight loss, a cancelled ad comm, and the Fed lowers interest rates
A new threat to Merck’s blockbuster cancer treatment, Moderna’s cutbacks, and obesity drugs for kids
Summit’s upcoming cancer results, Recursion’s mixed data, and a new co-host
Jim Wilson’s next venture, a surprise startup shutdown, & Lilly’s Zepbound strategy
Listen: BioMarin’s executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion’s AI bona fides
Listen: Drug pricing drops & psychedelics under fire
All Coverage
advertisement
